US Patent Issued to IMMUNIC on Oct. 7 for "Treatment of multiple sclerosis comprising DHODH inhibitors" (German Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,860, issued on Oct. 7, was assigned to IMMUNIC AG (Grafelfing, Germany).

"Treatment of multiple sclerosis comprising DHODH inhibitors" was invented by Andreas Muhler (Munich), Hella Kohlhof (Munich) and Daniel Vitt (Germering, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods of treating or ameliorating multiple sclerosis by the dihydroorotate dehydrogenase (DHODH) inhibitor vidofludimus or a pharmaceutically acceptable salt and/or a solvate, in particular a hydrate, thereof or a solvate, in particular a hydrate, of a pharmaceutically acceptable salt thereof, by administering to a human patient a therapeutically effective amount of the D...